NCT06285825View on ClinicalTrials.gov

A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia

PHASE2RecruitingINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

July 5, 2024

Primary Completion Date

August 22, 2026

Study Completion Date

August 22, 2028

Conditions

Cytopenia

Interventions

DRUG

Emapalumab

Given by Infusion

Trial Locations (1)

77030

RECRUITING

MD Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

Sobi, Inc.

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER